Company Focuses on Commercial Development, Revenue Generation and Operating Excellence JUPITER, Fla., Feb. 1, 2021 /PRNewswire/ — Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has added two life science industry […]
Author: Ken Dropiewski
Biomodex Teams Up with Physicians at Three of the World’s Top Medical Centers to Develop a Cutting-Edge Training Solution for Treatment of Ischemic Stroke
Lifelike tool enables neurointerventionalists to simulate fluoroscopy-guided procedures and validate success removing blockages from different artery access points in a variety of anatomies BOSTON, Feb. 1, 2021 /PRNewswire/ — BIOMODEX®, a pioneering digital health company that offers a unique and enhanced 3D printed solution for physician training, announced today the company has partnered […]
Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa®
– LYPDISO™ demonstrated a statistically significant 46% relative percent increase in EPA change from baseline over Vascepa® – – LYPDISO™ demonstrated a 39% relative difference in response over Vascepa in TG reduction – – Primary endpoint of percent change from baseline to end of treatment in triglycerides in the pharmacodynamic population did not meet […]
CARMAT Appoints Prof. Christian Latrémouille as Director of Surgical Affairs
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces the appointment of Professor Christian Latrémouille as Director of […]
NTT Research Names Jon Peterson MEI Lab Senior Scientist
Biomedical engineer specialized in cardiovascular systems to support bio digital twin initiative SUNNYVALE, Calif.–(BUSINESS WIRE)–NTT Research, Inc., a division of NTT (TYO:9432), today announced that it has named Dr. Jon Nels Peterson a Senior Scientist in its Medical & Health Informatics (MEI) Lab. Dr. Peterson, a biomedical engineer with both academic and medical […]
Canon Medical’s AI-Based Image Reconstruction Technology Now Available for 96 Percent of Procedures Using 1.5T MR
Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) Technology Expands to Wider Range of Clinical Applications for the Vantage Orian 1.5T MR System TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical is bringing the power of accessible artificial intelligence (AI) for improved image quality to more patients with expanded clinical indications for 1.5T […]
ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules
BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Prazosin HCl Capsules USP, 1mg and 2mg, following the U.S. Food and Drug Administration’s (“FDA”) approval of the Company’s prior approval supplement application (“PAS”). The current annual U.S. market for Prazosin 1mg and 2mg […]
Cagent Vascular Announces PRELUDE-BTK Study Results Presented at LINC Symposium: Confirms Serranator Device Novel Mechanism of Action
WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, a developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its PRELUDE-BTK Study at this year’s LINC Symposium on January 29th. The PRELUDE-BTK Study, was a prospective, single-arm, multi-center feasibility study to show the safety and efficacy of Serration Angioplasty. The […]
FEops Announces 2.000 Patients Modelled With FEops HEARTguide™
GENT, Belgium–(BUSINESS WIRE)–FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce having modeled 2000 patients with FEops HEARTguide™ for the pre-operative planning of structural heart interventions. FEops HEARTguide™ is currently commercially available in the European Union, Canada and Australia for its TAVI […]
Veteran Cardiology Medtech Executive Tim O’Malley Joins iMedrix Mobile Cardiology as CEO
KardioScreen-Intelligent Medical Metrics in Cardiology allowing for medical grade diagnostics while in a Mobile environment MILPITAS, Calif., Jan. 29, 2021 /PRNewswire/ — Tim O’Malley, has joined iMedrix Inc. manufacturer of KardioScreen, the world’s first medical-grade mobile cardiac monitoring device, as its new Chief Executive Officer. Mr. O’Malley joins the firm from EarlySense Inc., where he was […]



